Heartland Advisors Inc. Purchases New Position in Molina Healthcare, Inc $MOH

Posted by Brenda Bartman on Jun 11th, 2026

Heartland Advisors Inc. acquired a new position in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 40,805 shares of the company’s stock, valued at approximately $7,081,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. CenterBook Partners LP raised its stake in shares of Molina Healthcare by 359.7% in the third quarter. CenterBook Partners LP now owns 20,409 shares of the company’s stock worth $3,905,000 after acquiring an additional 15,969 shares during the last quarter. BNP Paribas Financial Markets grew its stake in shares of Molina Healthcare by 63.0% during the fourth quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock valued at $76,248,000 after purchasing an additional 169,739 shares during the last quarter. Fiera Capital Corp increased its holdings in shares of Molina Healthcare by 68.8% in the third quarter. Fiera Capital Corp now owns 241,581 shares of the company’s stock valued at $46,229,000 after purchasing an additional 98,431 shares in the last quarter. DDD Partners LLC acquired a new stake in shares of Molina Healthcare in the third quarter valued at approximately $1,743,000. Finally, Timber Creek Capital Management LLC bought a new position in Molina Healthcare in the 3rd quarter worth approximately $4,467,000. 98.50% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Mizuho set a $215.00 price objective on Molina Healthcare in a report on Monday. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $129.00 target price on shares of Molina Healthcare in a research note on Friday, April 24th. Robert W. Baird upped their price target on Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Wall Street Zen upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Truist Financial lifted their price objective on Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a research report on Monday, May 11th. Three analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $182.73.

Check Out Our Latest Research Report on Molina Healthcare

Molina Healthcare Price Performance

Shares of MOH stock opened at $197.96 on Thursday. The firm’s 50 day moving average price is $172.30 and its two-hundred day moving average price is $163.88. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $311.52. The stock has a market cap of $10.31 billion, a PE ratio of 58.57 and a beta of 0.80.

Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. During the same quarter in the prior year, the business posted $6.08 EPS. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts forecast that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insider Activity

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.44% of the company’s stock.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.